Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-05-29 Sale | 2026-06-01 5:35 pm | CRISPR Therapeutics AG | CRSP | Patel Naimish Chief Medical Officer | 3,786 | $55.62 | $210,577 | 39,357 (Direct) | View |
| 2026-03-16 Sale | 2026-03-17 5:37 pm | CRISPR Therapeutics AG | CRSP | Patel Naimish Chief Medical Officer | 3,150 | $48.26 | $152,019 | 37,518 (Direct) | View |
| 2025-04-03 Purchase | 2026-01-27 5:35 pm | CRISPR Therapeutics AG | CRSP | Patel Naimish Chief Medical Officer | 1,508 | $32.96 | $49,704 | 1,508 (Direct) | View |
| 2025-05-29 Sale | 2025-05-30 5:00 pm | CRISPR Therapeutics AG | CRSP | Patel Naimish Chief Medical Officer | 3,932 | $35.94 | $141,316 | 36,068 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-09-11 Option Award | 2026-09-15 4:06 pm | N/A 2036-01-15 | AgomAb Therapeutics NV | AGMB | Patel Naimish Director | 56,328 | $0 | 56,328 (Direct) | View |
| 2026-05-29 Option Award | 2026-06-02 5:41 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Patel Naimish Chief Medical Officer | 22,000 | $0 | 22,000 (Direct) | View |
| 2026-05-28 Exercise | 2026-06-01 5:35 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Patel Naimish Chief Medical Officer | 10,000 | $0 | 39,357 (Direct) | View |
| 2026-03-20 Option Award | 2026-03-24 5:36 pm | N/A 2036-03-20 | CRISPR Therapeutics AG | CRSP | Patel Naimish Chief Medical Officer | 68,499 | $0 | 68,499 (Direct) | View |
| 2026-03-14 Exercise | 2026-03-17 5:37 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Patel Naimish Chief Medical Officer | 8,125 | $0 | 37,518 (Direct) | View |
| 2025-10-03 Option Award | 2025-10-03 5:37 pm | N/A 2035-10-03 | CRISPR Therapeutics AG | CRSP | Patel Naimish Chief Medical Officer | 16,500 | $0 | 16,500 (Direct) | View |
| 2025-05-30 Option Award | 2025-06-03 9:45 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Patel Naimish Chief Medical Officer | 25,000 | $0 | 25,000 (Direct) | View |
| 2025-05-28 Exercise | 2025-05-30 5:00 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Patel Naimish Chief Medical Officer | 10,000 | $0 | 36,068 (Direct) | View |
| 2025-03-14 Option Award | 2025-03-18 5:35 pm | N/A 2035-03-14 | CRISPR Therapeutics AG | CRSP | Patel Naimish Chief Medical Officer | 79,167 | $0 | 79,167 (Direct) | View |
| 2024-10-16 Option Award | 2024-10-18 5:35 pm | N/A 2034-10-16 | CRISPR Therapeutics AG | CRSP | Patel Naimish Chief Medical Officer | 18,333 | $0 | 18,333 (Direct) | View |
| 2024-05-28 Option Award | 2024-05-29 4:15 pm | N/A 2034-05-28 | CRISPR Therapeutics AG | CRSP | Patel Naimish Chief Medical Officer | 125,000 | $0 | 125,000 (Direct) | View |